OOncovision — Seed (estimated)
Bullnet Capital became Oncovision's first institutional investor, putting money in through its first fund, Bullnet Capital I, in Q3 (August) 2006. The amount was not disclosed. Bullnet stayed on as a backer and later sold into Bruker's 2016 purchase of the Albira preclinical line.
Lead unknown
RoundSeed (estimated)
AnnouncedAug 2006
CityValencia
SectorHealthtech & Bio · Medtech
Source
B
B